In rat studies, Pratt found GLP-1 activation in a reward region blunted opioid-driven binge eating. His lab is now looking at another gut peptide, GRP.
Recap by typeshit. Full story at Newswise.
Pratt, a psychology professor who studies the circuits behind food motivation, walks through what neuroscience shows about these drugs.
Lilly's pill had major heart events in 4.2% of patients vs 5.0% on insulin glargine. The Clinical Trial Vanguard argues rivals now need to show benefit, not just safety.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
Among about 1,440 users, 56.8% of second-eye events came within six months versus 40.6% for non-users. Researchers stress it shows an association, not cause.
Novo says patients looked about two to three years younger on proteomic clocks across 10,052 people. Aging clock pioneer Steve Horvath calls it a strong effect.
Loading…